Della Porta Matteo Giovanni
Della Porta Matteo Giovanni
Professor of Hematology, Humanitas University, Milan - Italy
Verified email at
Cited by
Cited by
Revised international prognostic scoring system for myelodysplastic syndromes
PL Greenberg, H Tuechler, J Schanz, G Sanz, G Garcia-Manero, F Solé, ...
Blood 120 (12), 2454-2465, 2012
Clinical and biological implications of driver mutations in myelodysplastic syndromes
E Papaemmanuil, M Gerstung, L Malcovati, S Tauro, G Gundem, ...
Blood 122 (22), 3616-3627, 2013
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.
L Malcovati, U Germing, A Kuendgen, MG Della Porta, C Pascutto, ...
Journal of clinical oncology 25 (23), 3503-3510, 2007
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, ...
New England Journal of Medicine 365 (15), 1384-1395, 2011
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making
L Malcovati, MGD Porta, C Pascutto, R Invernizzi, M Boni, E Travaglino, ...
Journal of Clinical Oncology 23 (30), 7594-7603, 2005
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
L Malcovati, E Hellström-Lindberg, D Bowen, L Ades, J Cermak, ...
Blood 122 (17), 2943-2964, 2013
CD34+ and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure
M Valgimigli, GM Rigolin, A Fucili, MD Porta, O Soukhomovskaia, ...
Circulation 110 (10), 1209-1212, 2004
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
L Malcovati, E Papaemmanuil, DT Bowen, J Boultwood, MG Della Porta, ...
Blood, The Journal of the American Society of Hematology 118 (24), 6239-6246, 2011
The genetic basis of myelodysplasia and its clinical relevance
M Cazzola, MG Della Porta, L Malcovati
Blood 122 (25), 4021-4034, 2013
Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome
M Jadersten, L Malcovati, I Dybedal, M Giovanni Della Porta, R Invernizzi, ...
Journal of Clinical Oncology 26 (21), 3607-3613, 2008
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
L Malcovati, M Karimi, E Papaemmanuil, I Ambaglio, M Jädersten, ...
Blood 126 (2), 233-241, 2015
Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative …
F Passamonti, E Rumi, D Pietra, MGD Porta, E Boveri, C Pascutto, ...
Blood 107 (9), 3676-3682, 2006
Relative response of patients with myelodysplastic syndromes and other transfusion‐dependent anaemias to deferasirox (ICL670): a 1‐yr prospective study
J Porter, R Galanello, G Saglio, EJ Neufeld, E Vichinsky, MD Cappellini, ...
European journal of haematology 80 (2), 168-176, 2008
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile
M Valgimigli, GM Rigolin, C Cittanti, P Malagutti, S Curello, G Percoco, ...
European heart journal 26 (18), 1838-1845, 2005
Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)
L Malcovati, MG Della Porta, C Strupp, I Ambaglio, A Kuendgen, ...
Haematologica 96 (10), 1433, 2011
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia
J Boultwood, J Perry, A Pellagatti, M Fernandez-Mercado, ...
Leukemia 24 (5), 1062-1065, 2010
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes
MG Della Porta, L Malcovati, E Boveri, E Travaglino, D Pietra, C Pascutto, ...
Journal of clinical oncology 27 (5), 754-762, 2009
Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes
AA Van De Loosdrecht, C Alhan, MC Béné, MG Della Porta, AM Dräger, ...
haematologica 94 (8), 1124, 2009
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
PS Woll, U Kjällquist, O Chowdhury, H Doolittle, DC Wedge, S Thongjuea, ...
Cancer cell 25 (6), 794-808, 2014
Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome
MG Della Porta, L Malcovati, C Strupp, I Ambaglio, A Kuendgen, ...
Haematologica 96 (3), 441, 2011
The system can't perform the operation now. Try again later.
Articles 1–20